Clinical Trial Update: Collagen-Gentamicin Implant in the Treatment of Contaminated Surgical Abdominal Wounds [Phase 2]

View source ↗

Summary

A Phase II trial evaluating a collagen-gentamicin implant for superficial surgical site infections in contaminated abdominal wounds was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Surgical Site Infection

Drugs mentioned

• Collagen-Gentamicin Implant (collagen-gentamicin implant)

Snippet

Sponsor: Singapore General Hospital | Conditions: Superficial Surgical Site Infection | Phase 2 | Status: TERMINATED